Comments
Analysis: Heart device troubles cloud St Jude's outlook
14.04.2012. | CHICAGO (Reuters) - Twin setbacks for St Jude Medical Inc's heart rhythm devices are raising concerns on Wall Street that doctors will curb use of the company's products, weakening its position in the $6.5 billion global market for implantable defibrillators....
